PharmaDossierIndependent biopharma information, guidance, and source-cited analysis.

PHARMApharmadossier

Topic

CGRP

CGRP migraine preventives, access criteria, step therapy, specialty routing, and comparison evidence.

2 articles·Lives underPricing & Access Specialty·Last updated 2026-06-21

Evidence· June 21, 2026 · 9 min read

CGRP inhibitors in FAERS: 120,759 adverse-event reports by the numbers

By Ran Chen#Real-World Evidence #Label Warnings #Postmarketing Requirements

Pricing & Access· May 25, 2026 · 9 min read

CGRP inhibitor access landscape: eight drugs, coverage, and payer criteria in 2026

By Ran Chen#CGRP #CNS and Migraine #Coverage Access